World's Best Scientists 2026 revealed!
Nancy J. Sullivan

Nancy J. Sullivan

D-Index & Metrics

Microbiology

D-Index
64
Citations
18767
World Ranking
2580
National Ranking
1038

Overview

Nancy J. Sullivan is affiliated with Boston University in the United States. Their research primarily focuses on the field of Medicine, with a significant emphasis on Infectious Diseases. Other subfields of study include Molecular Biology, Epidemiology, Animal Science and Zoology, and Immunology.

The areas of research coverage prominently include:

  • SARS-CoV-2 and COVID-19 Research
  • Viral Infections and Outbreaks Research
  • COVID-19 Clinical Research Studies
  • Viral Infections and Vectors
  • Animal Virus Infections Studies
  • Viral gastroenteritis research and epidemiology
  • Immunotherapy and Immune Responses

The scientist has published extensively across several influential scientific journals and preprint archives. Frequent publication venues are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Science
  • Science Translational Medicine
  • New England Journal of Medicine
  • Cell Reports

Nancy J. Sullivan's recent notable papers include:

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, 2020, New England Journal of Medicine
  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters, 2022, Nature
  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine, 2021, New England Journal of Medicine
  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants, 2022, Cell Reports
  • Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates, 2021, Science

The scientist has collaborated frequently with several co-authors, including:

  • John R. Mascola
  • Lingshu Wang
  • Juan I. Moliva
  • Barney S. Graham
  • Peter D. Kwong

Best Publications

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters

    Unknown

  • Endosomal Proteolysis of the Ebola Virus Glycoprotein Is Necessary for Infection

    Kartik Chandran;Nancy J. Sullivan;Ute Felbor;Sean P. Whelan

  • Development of a preventive vaccine for Ebola virus infection in primates

    Nancy J. Sullivan;Anthony Sanchez;Pierre E. Rollin;Zhi Yong Yang

  • Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

    Steven M. Jones;Heinz Feldmann;Heinz Feldmann;Ute Ströher;Ute Ströher;Joan B. Geisbert

  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

    Unknown

  • Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

    Nancy J. Sullivan;Thomas W. Geisbert;Joan B. Geisbert;Ling Xu

  • Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

    Zhi Yong Yang;Henricus J. Duckers;Nancy J. Sullivan;Anthony Sanchez

  • A Recombinant Vesicular Stomatitis Virus Ebola Vaccine — Preliminary Report

    Jason A. Regules;John H. Beigel;Kristopher M. Paolino;Jocelyn Voell

  • Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

    Davide Corti;John Misasi;Sabue Mulangu;Daphne A. Stanley

  • Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine.

    Kai Wu;Anne P Werner;Matthew Koch;Angela Choi

  • Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

    Daphne A Stanley;Anna N Honko;Anna N Honko;Clement Asiedu;John C Trefry

  • Chimpanzee Adenovirus Vector Ebola Vaccine

    Julie E. Ledgerwood;Adam D. DeZure;Daphne A. Stanley;Emily E. Coates

  • mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

    Unknown

  • A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

    Katie Ewer;Tommy Rampling;Navin Venkatraman;Georgina Bowyer

  • Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys

    Wendelien B Oswald;Thomas W Geisbert;Kelly J Davis;Joan B Geisbert

  • A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial

    Julie E Martin;Nancy J Sullivan;Mary E Enama;Ingelise J Gordon

  • Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule.

    Nancy J. Sullivan;Julie E. Martin;Barney S. Graham;Gary J. Nabel

  • Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.

    Kizzmekia S. Corbett;Martha C. Nason;Britta Flach;Matthew Gagne

  • Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

    Unknown

  • CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

    Nancy J Sullivan;Lisa Hensley;Clement Asiedu;Thomas W Geisbert

  • Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge

    Thomas W. Geisbert;Michael Bailey;Lisa Hensley;Clement Asiedu

  • Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs.

    Nancy J Sullivan;Thomas W Geisbert;Joan B Geisbert;Devon J Shedlock

  • Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

    Milagritos D. Tapia;Samba O. Sow;Kirsten E. Lyke;Fadima Cheick Haidara

Frequent Co-Authors

Barney S. Graham
Barney S. Graham Morehouse School of Medicine
Anthony Sanchez
Anthony Sanchez University of Perpignan
Zhi-Yong Yang
Zhi-Yong Yang ModeX Therapeutics LLC
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Lawrence Shapiro
Lawrence Shapiro Columbia University
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
Kizzmekia S. Corbett
Kizzmekia S. Corbett Harvard University
Karin Loré
Karin Loré Karolinska Institute
Wei Shi
Wei Shi Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers related to Microbiology often leads students to consider diverse healthcare and scientific fields. For those interested in administrative roles within healthcare settings, the fastest online medical billing and coding certificate programs offer a quick pathway into essential medical office functions. These programs provide specialized skills that complement microbiological knowledge in healthcare environments.

Many students also pursue advanced education through various online medical programs, which allow flexibility while expanding expertise in areas like public health, clinical research, or laboratory technology. These programs can be pivotal for microbiologists aiming for roles in healthcare innovation or patient care management.

For those considering public health careers, the fastest and easiest online MPH programs enable swift entry into the field, often with part-time study options. An MPH degree can enhance opportunities in epidemiology, environmental health, and policy-making, areas closely aligned with microbiology.

Additionally, careers such as child life specialists demonstrate unique intersections between healthcare and support services. Understanding how much do child life specialists make can help microbiology graduates evaluate diverse healthcare career pathways, especially those focused on patient experience and well-being.

Best Scientists Citing Nancy J. Sullivan

Trending Scientists

Recently Published Articles